Time-to-Readiness as a Commercial Metric: Why Finance Cares More Than L&D Thinks

There is a number that finance teams care about deeply but rarely discuss with L&D: how many days it takes a new sales rep to become genuinely competent in the field. Not certified. Not "onboarded." Competent. Able to have a credible clinical conversation, handle objections from experienced HCPs, and advance an opportunity without constant hand-holding from their manager.

This number is time-to-readiness, and it should be the single most important metric in any commercial training function. It is not, in most organisations. Instead, training teams track completion rates, satisfaction scores, and certification dates. These metrics tell you whether people attended training. They tell you nothing about whether that training produced someone who can actually sell.

Why finance cares

Finance sees headcount in terms of revenue capacity. When a territory is vacant or staffed by someone who is not yet productive, that capacity sits idle. The cost is not hypothetical. It is measurable.

Consider a sales rep with a £500,000 annual quota. That works out to roughly £1,370 per selling day (assuming around 365 days with weekends, bank holidays, and internal meetings removed, you get approximately 230 selling days). Every day that rep is not ready to sell independently is £1,370 in potential revenue that is not being pursued.

Now consider the maths at scale. If your average time-to-readiness is 120 days and you reduce it to 75 days, you have recovered 45 selling days per rep. At £1,370 per day, that is approximately £62,000 per rep in accelerated pipeline opportunity. For a cohort of 20 new hires, that is £1.24 million in revenue capacity that becomes available sooner.

Finance teams understand this calculation intuitively. They do not need to be convinced that faster readiness matters. What they need is for L&D to start measuring and reporting in these terms.

The measurement problem

Most organisations do not know their actual time-to-readiness because they are measuring the wrong thing. They measure time-to-certification: the date a rep completes their training programme and receives permission to operate in the field. This date typically falls somewhere between 4 and 12 weeks after start date, depending on the complexity of the product portfolio and regulatory requirements.

But certification date and readiness date are different things. Certification says "this person has passed the required knowledge assessments and observed roleplays." Readiness says "this person can operate independently and produce results."

The gap between those two dates is where money goes to die.

I have seen organisations where reps are certified at week 6 but do not close their first deal until week 18. That 12-week gap represents a period where the rep is technically in the field but functionally still developing. They are making calls, but those calls are not productive. They are in front of HCPs, but those conversations are not advancing anything. They are occupying a territory, but they are not covering it effectively.

How to measure time-to-readiness properly

There are several legitimate approaches to defining the "readiness" point. The best choice depends on your sales cycle and commercial model.

First independently-managed territory call. This is the first time a rep conducts a complete sales interaction without their manager present and without needing to follow up with corrections or additional information. It is not the first call they make alone. It is the first call they make alone that does not require cleanup.

First closed opportunity. In transactional selling environments, this works well. The rep either converts or they do not. The first conversion is a reasonable proxy for readiness. In longer-cycle enterprise selling (capital equipment, for instance), this metric may take too long to be useful.

Manager assessment of independent operation. Ask the manager: "Would you be comfortable leaving this rep unsupervised in any account in their territory?" When the answer shifts from no to yes, that is readiness. This is subjective, but managers generally know. The risk is that some managers are overly generous in their assessments.

Composite activity metrics. Track call frequency, opportunity creation rate, pipeline progression, and customer engagement scores. When these metrics reach a threshold (typically 70-80% of the team average for tenured reps), the new hire is functionally ready.

Whatever method you choose, the critical point is that it should be based on demonstrated performance, not on the completion of a training programme.

Why it beats training completion as a budget metric

When L&D teams justify their budget using completion rates, they are essentially saying "we spent money and people showed up." This is a weak argument in any budget negotiation. Finance can always counter with "could they have shown up to something cheaper?"

Time-to-readiness changes the conversation entirely. Instead of "we trained 200 people this year," you can say "we reduced time-to-readiness from 120 days to 75 days, which generated £1.2m in accelerated revenue capacity for the last cohort alone." One of those statements gets a polite nod. The other gets budget approval.

The reason this works is that time-to-readiness connects training directly to commercial outcomes. It is not a proxy. It is not an assumption. It is a direct measurement of how quickly training produces someone who generates revenue.

It also forces honest conversations about training effectiveness. If you redesign your onboarding programme and time-to-readiness does not improve, the programme did not work. That is uncomfortable information, but it is better than spending years delivering ineffective training and measuring success by how many people completed it.

What actually compresses time-to-readiness

If the goal is to reduce the number of days between start date and genuine field competence, you need to understand what fills those days currently.

In a typical life sciences onboarding programme, the first few weeks involve product knowledge training. Reps learn the clinical data, the indications, the competitive positioning, the pricing, the access pathways. This is necessary and largely irreducible. You cannot shortcut the need to understand what you are selling.

The next phase is skills development. Reps learn how to structure conversations, handle objections, present data, ask questions, and close. This is where most time is lost, not because the training is slow, but because the practice is insufficient.

Consider the traditional model. A rep attends a three-day training course on consultative selling. They do a few roleplays with colleagues. They get certified. Then they go into the field and discover that real conversations bear little resemblance to the controlled environment of the training room. They spend weeks figuring out what actually works through trial and error, mostly with real customers.

AI coaching compresses this phase dramatically, especially when reps practise daily rather than weekly. Instead of three roleplays during training week and then nothing, reps can practise twenty or thirty realistic conversations before they ever meet a customer. They can rehearse against different HCP archetypes. They can practise handling the specific objections they will encounter in their territory. They can repeat scenarios until their responses become natural rather than rehearsed.

The compression happens because practice frequency increases by an order of magnitude. A rep who does three roleplays during training gets three iterations of feedback. A rep who does thirty AI-coached practice sessions gets thirty iterations. The skill development that used to take weeks of field experience can happen in days of intensive practice.

The compounding effect

Time-to-readiness matters most when you consider it across the entire commercial organisation over time. A single rep reaching readiness 45 days earlier is worth approximately £62,000 in accelerated capacity. But commercial organisations are constantly hiring. Turnover in life sciences sales sits at 15-25% annually, which means a 200-person sales force is hiring 30-50 new reps every year.

If each of those reps reaches readiness 45 days earlier, the annual impact across the organisation is between £1.86m and £3.1m in accelerated revenue capacity. That is not a training metric. That is a commercial performance metric. And it recurs every year.

This is why finance cares. Not because they are interested in learning theory or instructional design. Because time-to-readiness directly affects revenue forecasts, territory coverage, and commercial capacity planning.

Making the business case

If you want to use time-to-readiness to justify training investment, you need to do three things.

First, establish a baseline. Measure your current time-to-readiness using one of the methods above. Be honest about the number. Most organisations significantly underestimate it because they conflate certification with readiness.

Second, set a target. Based on the interventions you plan to implement (more practice, better coaching, AI-supported development), estimate a realistic reduction. A 25-35% reduction is achievable with significant changes to how practice is delivered. A 10-15% reduction is achievable with incremental improvements.

Third, calculate the financial impact. Use your quota data to determine the daily revenue capacity per rep, multiply by the number of days saved, and scale by cohort size. Present this to finance in their language: accelerated revenue capacity, reduced time to productivity, faster return on hiring investment.

When you present time-to-readiness as a commercial metric rather than a training metric, you stop being a cost centre asking for budget. You become a revenue function demonstrating return on investment, ready to answer the CFO's question with commercial data rather than completion rates.

The organisational shift

Adopting time-to-readiness as a primary metric requires a shift in how training teams think about their work. It is no longer sufficient to design good training. You need to design training that produces readiness quickly. Those are not the same thing.

Good training might involve extensive classroom time, deep product knowledge modules, and thorough compliance coverage. Training that produces readiness quickly might involve less classroom time, more practice time, faster access to realistic scenarios, and earlier exposure to field conditions.

This can create tension. Training teams are often proud of their comprehensive programmes. Suggesting that comprehensiveness might slow down readiness is not always welcome. But the data usually supports a more practice-intensive, less content-heavy approach to skill development.

The best onboarding programmes give reps the minimum viable knowledge to begin practising, then layer additional knowledge around ongoing practice, an approach we detail in onboarding is not training. They do not wait until all knowledge is delivered before practice begins. They interleave the two, using practice to create context for knowledge and knowledge to inform practice.

What to do on Monday morning

If you run a training function in life sciences and you are not currently tracking time-to-readiness, start. Pick a cohort of recent hires and work backwards. When did they start? When did they become genuinely productive? The gap between those dates is your current time-to-readiness.

Then ask yourself: what would it be worth to reduce that gap by 30%? Do the maths with your own quota numbers and cohort sizes. The answer will almost certainly be large enough to justify significant investment in better practice infrastructure.

Finance already thinks about rep productivity in terms of time. They just do not realise that L&D can influence it. Show them you can, and budget conversations become considerably easier.